These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34880258)

  • 1. Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease.
    Pal G; Ramirez V; Engen PA; Naqib A; Forsyth CB; Green SJ; Mahdavinia M; Batra PS; Tajudeen BA; Keshavarzian A
    NPJ Parkinsons Dis; 2021 Dec; 7(1):111. PubMed ID: 34880258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and nasal microbiota in Parkinson's disease.
    Pereira PAB; Aho VTE; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Parkinsonism Relat Disord; 2017 May; 38():61-67. PubMed ID: 28259623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
    Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
    Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
    Li C; Cui L; Yang Y; Miao J; Zhao X; Zhang J; Cui G; Zhang Y
    Front Mol Neurosci; 2019; 12():171. PubMed ID: 31354427
    [No Abstract]   [Full Text] [Related]  

  • 5. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the nasal microbiota in granulomatosis with polyangiitis.
    Rhee RL; Sreih AG; Najem CE; Grayson PC; Zhao C; Bittinger K; Collman RG; Merkel PA
    Ann Rheum Dis; 2018 Oct; 77(10):1448-1453. PubMed ID: 29997110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Western Diet and Oral Microbiota in Parkinson's Disease.
    Zapała B; Stefura T; Milewicz T; Wątor J; Piwowar M; Wójcik-Pędziwiatr M; Doręgowska M; Dudek A; Jania Z; Rudzińska-Bar M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaching the Gut and Nasal Microbiota in Parkinson's Disease in the Era of the Seed Amplification Assays.
    Consonni A; Miglietti M; De Luca CMG; Cazzaniga FA; Ciullini A; Dellarole IL; Bufano G; Di Fonzo A; Giaccone G; Baggi F; Moda F
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging-A Review.
    Thangaleela S; Sivamaruthi BS; Kesika P; Bharathi M; Chaiyasut C
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16S Metagenomics Reveals Dysbiosis of Nasal Core Microbiota in Children With Chronic Nasal Inflammation: Role of Adenoid Hypertrophy and Allergic Rhinitis.
    Marazzato M; Zicari AM; Aleandri M; Conte AL; Longhi C; Vitanza L; Bolognino V; Zagaglia C; De Castro G; Brindisi G; Schiavi L; De Vittori V; Reddel S; Quagliariello A; Del Chierico F; Putignani L; Duse M; Palamara AT; Conte MP
    Front Cell Infect Microbiol; 2020; 10():458. PubMed ID: 32984078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Dysbiosis and Inflammation in Parkinson's Disease.
    Fleury V; Zekeridou A; Lazarevic V; Gaïa N; Giannopoulou C; Genton L; Cancela J; Girard M; Goldstein R; Bally JF; Mombelli A; Schrenzel J; Burkhard PR
    J Parkinsons Dis; 2021; 11(2):619-631. PubMed ID: 33646178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota.
    Li C; Hou Y; Wang X; Li YX; Li F; Zhang C; Li WG
    Front Neurol; 2021; 12():653833. PubMed ID: 33889128
    [No Abstract]   [Full Text] [Related]  

  • 18. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory bulb surroundings can help to distinguish Parkinson's disease from non-parkinsonian olfactory dysfunction.
    Tremblay C; Mei J; Frasnelli J
    Neuroimage Clin; 2020; 28():102457. PubMed ID: 33068873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.